|
|
|
|
Дата |
|---|
| 05.06.2026 |
| 04.06.2026 |
| 03.06.2026 |
| 02.06.2026 |
| 01.06.2026 |
| 29.05.2026 |
| 28.05.2026 |
| 27.05.2026 |
| 26.05.2026 |
| 25.05.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
97.10
|
96.00
|
99.80
|
96.00
|
|
|
416 006 742.00
|
3 810.00
|
|
|
|
98.00
|
96.40
|
101.50
|
96.40
|
|
|
567 233 269.00
|
4 799.00
|
|
|
|
97.20
|
96.50
|
98.00
|
96.50
|
|
|
252 307 871.00
|
2 950.00
|
|
|
|
98.60
|
96.70
|
99.60
|
96.80
|
|
|
356 371 067.00
|
4 174.00
|
|
|
|
101.50
|
98.50
|
102.50
|
98.60
|
|
|
500 502 322.00
|
4 802.00
|
|
|
|
100.00
|
99.20
|
104.50
|
100.50
|
|
|
1 104 872 551.00
|
5 153.00
|
|
|
|
98.10
|
98.00
|
102.00
|
98.00
|
|
|
415 642 617.00
|
3 790.00
|
|
|
|
102.00
|
98.50
|
102.50
|
98.50
|
|
|
603 768 005.00
|
23 187.00
|
|
|
|
110.00
|
102.00
|
110.00
|
102.50
|
|
|
621 927 700.00
|
24 572.00
|
|
|
|
106.00
|
104.00
|
111.50
|
108.00
|
|
|
1 008 209 326.00
|
9 966.00
|
Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.
